Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Investigation of the mechanism of dipyridamole action in platelets in an in-vivo study with
healthy volunteers treated Aggrenox in comparison with volunteers treated with Persantin
Retard or Acetylsalicylic Acid using platelet Vasodilator-Stimulated-Phosphoprotein
(VASP)-phosphorylation as indication for an action and measurements of dipyridamole plasma
levels
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Aspirin Aspirin, Dipyridamole Drug Combination Dipyridamole